164 related articles for article (PubMed ID: 31417180)
1. T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
Buffière A; Uzan B; Aucagne R; Hermetet F; Mas M; Nassurdine S; Aznague A; Carmignac V; Tournier B; Bouchot O; Ballerini P; Barata JT; Bastie JN; Delva L; Pflumio F; Quéré R
Oncogene; 2019 Nov; 38(48):7357-7365. PubMed ID: 31417180
[TBL] [Abstract][Full Text] [Related]
2. Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
De Smedt R; Morscio J; Reunes L; Roels J; Bardelli V; Lintermans B; Van Loocke W; Almeida A; Cheung LC; Kotecha RS; Mansour MR; Uyttebroeck A; Vandenberghe P; La Starza R; Mecucci C; Lammens T; Van Roy N; De Moerloose B; Barata JT; Taghon T; Goossens S; Van Vlierberghe P
Blood; 2020 May; 135(19):1685-1695. PubMed ID: 32315407
[TBL] [Abstract][Full Text] [Related]
3. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
[TBL] [Abstract][Full Text] [Related]
4. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.
Uzan B; Poglio S; Gerby B; Wu CL; Gross J; Armstrong F; Calvo J; Cahu X; Deswarte C; Dumont F; Passaro D; Besnard-Guérin C; Leblanc T; Baruchel A; Landman-Parker J; Ballerini P; Baud V; Ghysdael J; Baleydier F; Porteu F; Pflumio F
EMBO Mol Med; 2014 Jun; 6(6):821-34. PubMed ID: 24778454
[TBL] [Abstract][Full Text] [Related]
6. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
7. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
8. STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.
Ribeiro D; Melão A; van Boxtel R; Santos CI; Silva A; Silva MC; Cardoso BA; Coffer PJ; Barata JT
Blood Adv; 2018 Sep; 2(17):2199-2213. PubMed ID: 30185437
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL.
Rodriguez S; Abundis C; Boccalatte F; Mehrotra P; Chiang MY; Yui MA; Wang L; Zhang H; Zollman A; Bonfim-Silva R; Kloetgen A; Palmer J; Sandusky G; Wunderlich M; Kaplan MH; Mulloy JC; Marcucci G; Aifantis I; Cardoso AA; Carlesso N
Leukemia; 2020 May; 34(5):1241-1252. PubMed ID: 31772299
[TBL] [Abstract][Full Text] [Related]
10. MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance.
van der Zwet JCG; Buijs-Gladdines JGCAM; Cordo' V; Debets DO; Smits WK; Chen Z; Dylus J; Zaman GJR; Altelaar M; Oshima K; Bornhauser B; Bourquin JP; Cools J; Ferrando AA; Vormoor J; Pieters R; Vormoor B; Meijerink JPP
Leukemia; 2021 Dec; 35(12):3394-3405. PubMed ID: 34007050
[TBL] [Abstract][Full Text] [Related]
11. IL-7 contributes to the progression of human T-cell acute lymphoblastic leukemias.
Silva A; Laranjeira AB; Martins LR; Cardoso BA; Demengeot J; Yunes JA; Seddon B; Barata JT
Cancer Res; 2011 Jul; 71(14):4780-9. PubMed ID: 21593192
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway.
Shen Y; Park CS; Suppipat K; Mistretta TA; Puppi M; Horton TM; Rabin K; Gray NS; Meijerink JPP; Lacorazza HD
Leukemia; 2017 Jun; 31(6):1314-1324. PubMed ID: 27872496
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia.
Almeida RDS; Ramos AML; Luna CF; Pedrosa F; Donadi EA; Lucena-Silva N
Cytokine; 2018 Feb; 102():94-101. PubMed ID: 28802664
[TBL] [Abstract][Full Text] [Related]
14. Desperately seeking a home marrow niche for T-cell acute lymphoblastic leukaemia.
Calvo J; Fahy L; Uzan B; Pflumio F
Adv Biol Regul; 2019 Dec; 74():100640. PubMed ID: 31378700
[TBL] [Abstract][Full Text] [Related]
15. Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia.
Barata JT; Keenan TD; Silva A; Nadler LM; Boussiotis VA; Cardoso AA
Haematologica; 2004 Dec; 89(12):1459-67. PubMed ID: 15590396
[TBL] [Abstract][Full Text] [Related]
16. Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.
Bride KL; Vincent TL; Im SY; Aplenc R; Barrett DM; Carroll WL; Carson R; Dai Y; Devidas M; Dunsmore KP; Fuller T; Glisovic-Aplenc T; Horton TM; Hunger SP; Loh ML; Maude SL; Raetz EA; Winter SS; Grupp SA; Hermiston ML; Wood BL; Teachey DT
Blood; 2018 Mar; 131(9):995-999. PubMed ID: 29305553
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
18. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
19. CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance.
Pitt LA; Tikhonova AN; Hu H; Trimarchi T; King B; Gong Y; Sanchez-Martin M; Tsirigos A; Littman DR; Ferrando AA; Morrison SJ; Fooksman DR; Aifantis I; Schwab SR
Cancer Cell; 2015 Jun; 27(6):755-68. PubMed ID: 26058075
[TBL] [Abstract][Full Text] [Related]
20. The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia.
Han K; Wang Q; Cao H; Qiu G; Cao J; Li X; Wang J; Shen B; Zhang J
Oncotarget; 2016 Apr; 7(17):23812-24. PubMed ID: 26993774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
